Related Experiment Videos

Adrenergic beta 2-selective blocker in isoprenaline-enhanced essential tremor

H Teräväinen¹, J Huttunen

¹Department of Neurology, University of Helsinki, Finland.

Movement Disorders : Official Journal of the Movement Disorder Society

|January 1, 1987

Abstract:

A beta 2-selective adrenergic-receptor-blocking drug, ICI 118.551, 150 mg/day, prevented almost as effectively as the nonselective antagonist propranolol, 240 mg/day, the isoprenaline enhancement of essential tremor amplitude.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Outcome measures after anterior cervical decompression and fusion surgery -non-respondents do not bias the results: A Finnish spine register (FinSpine) study.

Brain & spine·2025

Increased Mortality Despite Successful Multifactorial Cardiovascular Risk Reduction in Healthy Men: 40-Year Follow-Up of the Helsinki Businessmen Study Intervention Trial.

The journal of nutrition, health & aging·2018

ViPAR: a software platform for the Virtual Pooling and Analysis of Research Data.

International journal of epidemiology·2015

Efficacy of stabilisation splint treatment on facial pain - 1-year follow-up.

Journal of oral rehabilitation·2015

Entacapone in combination with standard or controlled-release levodopa/carbidopa: a clinical and pharmacokinetic study in patients with Parkinson's disease.

European journal of neurology·2013

Positron emission tomography with [18F]flutemetamol and [11C]PiB for in vivo detection of cerebral cortical amyloid in normal pressure hydrocephalus patients.

European journal of neurology·2013

See all related articles